SECURITIES  AND EXCHANGE  COMMISSION  Washington,  D. C. 20549 SCHEDULE 13G
Under the Securities Exchange Act of 1934 (Amendment No. 1).
Aastrom Biosciences, Inc.
__________________________________________________________
       (Name of Issuer)

                ______________________Common Capital Stock_________________
(Title of Class of Securities)

00253U10
__________________________________________________________
                        (CUSIP)

 .       * The remainder of this cover page shall be filled out for a reporting
 person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ('Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).


CUSIP No. 00253U10
_____________________________________________________________________

1)      Names of Reporting Persons S. S. or I.R.S. Identification Nos. of Above

          Persons: The Kaufmann Fund, Inc. TIN # 13-2605091

2)      Check the Appropriate Box if a Member of a Group

(a)

(b)


3)      SEC Use Only:_______________________________


4)      Citizenship or Place of Organization: United States


        Number of       (5) Sole Voting Power: 2,550,000 shs:
        Shares Bene-
        ficially        (6) Shared Voting Power: N/A
        Owned by
        Each Report-    (7) Sole Dispositive Power: 2,550,000 shs
        ing Person
        With    (8) Shared Dispositive Power: N/A


9)      Aggregate Amount Beneficially Owned by Each Reporting Person:
        2,550,000 shs

        10)    Check if the Aggregate Amount in Row (9) Excludes Certain Shares:



11)  Percent of Class Represented by Amount in Row 9: 19.17 %


12)  Type of Reporting Person (See Instructions): IV





                                               Item 1(a)

Name of Issuer: Aastrom Biosciences, Inc.
Item l(b)
Address of Issuer's Principal Executive Office: Dominos Farms Lobbl L
                                                24 Frank Lloyd Wright Drive
                                                Ann Arbor, MI  48106    

                                                  Item 2(a)
Name of Person Filing: The Kaufmann Fund, Inc.
                                                  Item 2(b)

Address of Principal Business Office or, if none, Residence: 140 E. 45th Street,
43rd Floor, New York, NY 10017

                                                  Item 2(c)

Citizenship: United States

Item 2(d)

Title of Class of Securities: Common Capital Stock

                                                  Item 2(e)

CUSIP Number:
                                                                    Item 3

If this statement is filed pursuant to Rules 13d-l(b), or 13d-2(b), check
whether the person filing is a:

        (a)     ____Broker of Dealer registered under Section 15 of the Act.
        (b)     ____Bank as defined in section 3(a)(6) of the Act.
        (c)     ____Insurance Company as defined in section 3(a)(19) of the Act.
        (d)     _X__Investment Company registered under section 8 of the
                    Investment Company Act.
        (e)     ____Investment Adviser registered under section 203 of
                    the Investment Advisers Act of 1940.
`       (f)     ____Employee Benefit Plan, Pension Fund which is subject to
                    the provisions of the Employee Retirement Income
                    Security Act of 1974 or Endowment Fund; see Section
                    240.13d-l(b)(1)(ii)(F).
        (g)     ____Parent Holding Company in accordance with Section
                    240.13d-l(b)(ii)(G) (Note: See Item 7).
        (h)     ____Group, in accordance with Section 240-13d-l(b)(1)(ii)(H).


Item 4

Ownership.

If the percent of the class owned, as of December 31 of the year covered
 by the statement, or as of the last day of any month described in
Rule13d-1(b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a right to
acquire.

(a)     Amount Beneficially Owned: 2,550,000 shs

(b)     Percent of Class: 19.17 %

(c)     Number of shares as to which such person has:
(i)     sole power to vote or to direct the vote: 2,550,000 shs
(ii)    shared power to vote or to direct the vote :N/A
(iii)         sole power to dispose or to direct the disposition
         of: 2,550,000 shs
(iv)    shared power to dispose or to direct the disposition
         of: N/A
Instruction: For computations regarding securities which represent a right to
acquire an underlying security see Rule 13d-3(d)(1).
Item 5
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
 the reporting person has ceased to be the beneficial owner of more than five
 percent of the class of securities, check the following ( x )

Item 6
Ownership of More than Five Percent on Behalf of Another Person.  N/A



Item 7
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company. N/A

Item 8

Identification and Classification of Members of the Group.  N/A

Item 9

Notice of Dissolution of Group.  N/A

Item 10

Certification.

The following certification shall be included if the statement is filed
 pursuant to Rule 13d-l(b):

By signing below I certify that, to the best of my knowledge and belief,
 the securities referred to above were acquired in the ordinary course of
 business and were not acquired for the purpose of and do not have the effect
 of changing or influencing the control of the issuer of such securities and
 were not acquired in connection with or as a participant in an transaction
 having such purposes or effect.

Signature.

After reasonable inquiry and to the best of my knowledge and belief,
 I certify that the information set forth in this statement is true, complete
 and correct.


Date:  December 10, 1997

Signature___________________________

             ANTHONY W. TOOGOOD
                         Name

             __Vice-President_________
                     Title